BRIEF published on 12/17/2025 at 14:43, 7 months 21 days ago First Berlin Equity Research met à jour sa recommandation sur Cardiol Therapeutics, passant à « Acheter » avec un objectif de cours abaissé. Recommandation D'achat Ajustement Du Prix Cible Thérapeutique Cardiaque Étude ARCHER De Phase II Myocardite
PRESS RELEASE published on 12/17/2025 at 14:38, 7 months 21 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc., lowering price target to USD 7.80 based on positive Phase II ARCHER data on CardiolRx for acute myocarditis First Berlin Equity Research Buy Recommendation Acute Myocarditis Cardiol Therapeutics Inc. Phase II ARCHER Data
BRIEF published on 10/23/2025 at 12:56, 9 months 15 days ago Cardiol Therapeutics obtient un financement avec un placement privé de 11,4 millions de dollars Placement Privé Essais Cliniques Cardiol Therapeutics Perspectives Financières Traitement De L'insuffisance Cardiaque
BRIEF published on 10/23/2025 at 12:56, 9 months 15 days ago Cardiol Therapeutics Secures Funding with USD 11.4 Million Private Placement Private Placement Clinical Trials Financial Outlook Cardiol Therapeutics Heart-Failure Therapy
PRESS RELEASE published on 10/23/2025 at 12:51, 9 months 15 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates Cardiol Therapeutics Inc with a BUY rating and USD 8.50 price target. The private placement secures funds for pivotal trials and new product development Private Placement Cardiol Therapeutics Inc First Berlin Equity Research BUY Rating USD 8.50 Price Target
BRIEF published on 08/12/2025 at 13:36, 11 months 26 days ago Cardiol Therapeutics: Phase II Trial Results and Positive Stock Outlook BUY Rating Cardiol Therapeutics CardiolRx Phase II ARCHER Trial Acute Myocarditis
BRIEF published on 08/12/2025 at 13:36, 11 months 26 days ago Cardiol Therapeutics : résultats de l'essai de phase II et perspectives boursières positives Cardiol Therapeutics Acheter Une Note CardiolRx Essai ARCHER De Phase II Myocardite Aiguë
PRESS RELEASE published on 08/12/2025 at 13:31, 11 months 26 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc after positive phase II trial results for CardiolRx in acute myocarditis Cardiol Therapeutics Inc First Berlin Equity Research Phase II Trial CardiolRx Acute Myocarditis
BRIEF published on 04/23/2025 at 15:29, 1 year 3 months ago Cardiol Therapeutics Advances in Pivotal Phase III Study FDA Approval Cardiol Therapeutics Phase III Study Recurrent Pericarditis CardiolRxT
BRIEF published on 04/23/2025 at 15:29, 1 year 3 months ago Cardiol Therapeutics progresse dans l'étude pivot de phase III Cardiol Therapeutics Approbation De La FDA Étude De Phase III Péricardite Récurrente CardiolRxT
Published on 08/07/2026 at 14:17, 2 hours 46 minutes ago NuRAN Wireless Increases Series A Preferred Share Financing to C$7.6 Million and Announces Debt Settlements
Published on 08/07/2026 at 13:00, 4 hours 3 minutes ago Gold Terra Announces Start of Drilling on the Campbell Shear Northern Zone 103N Extension to Expand 2026 MRE of Inferred 595,000 Ounces, Con Mine, Yellowknife, NWT
Published on 08/07/2026 at 00:45, 16 hours 18 minutes ago NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 17 hours 48 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 18 hours 48 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/07/2026 at 15:39, 1 hour 24 minutes ago Predictiv AI Inc. Hires Aktien Media for Internet Advertising Services
Published on 08/07/2026 at 15:16, 1 hour 46 minutes ago Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
Published on 08/07/2026 at 15:06, 1 hour 56 minutes ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 08/07/2026 at 15:36, 1 hour 27 minutes ago NRJ Group - Information relative aux droits de vote au 31.07.2026 (French & English)
Published on 08/07/2026 at 08:30, 8 hours 33 minutes ago Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/07/2026 at 08:30, 8 hours 33 minutes ago Déclaration nombre d'actions et droits de vote - 07.08.2026
Published on 08/06/2026 at 18:26, 22 hours 37 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 22 hours 37 minutes ago Air Liquide droits de vote au 31 juillet 2026
